Items where Author is "Zhang, Shanshan"

Article

Cigliano, Antonio and Zhang, Shanshan and Ribback, Silvia and Steinmann, Sara and Sini, Marcella and Ament, Cindy E. and Utpatel, Kirsten and Song, Xinhua and Wang, Jingxiao and Pilo, Maria G. and Berger, Fabian and Wang, Haichuan and Tao, Junyan and Li, Xiaolei and Pes, Giovanni M. and Mancarella, Serena and Giannelli, Gianluigi and Dombrowski, Frank and Evert, Matthias and Calvisi, Diego F. and Chen, Xin and Evert, Katja (2022) The Hippo pathway effector TAZ induces intrahepatic cholangiocarcinoma in mice and is ubiquitously activated in the human disease. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 41 (1): 192. ISSN , 1756-9966

Wang, Haichuan and Zhang, Shanshan and Zhang, Yi and Jia, Jiaoyuan and Wang, Jingxiao and Liu, Xianqiong and Zhang, Jie and Song, Xinhua and Ribback, Silvia and Cigliano, Antonio and Evert, Matthias and Liang, Bingyong and Wu, Hong and Calvisi, Diego F. and Zeng, Yong and Chen, Xin (2022) TAZ is indispensable for c-MYC-induced hepatocarcinogenesis. JOURNAL OF HEPATOLOGY, 76 (1). pp. 123-134. ISSN 0168-8278, 1600-0641

Wang, Haichuan and Wang, Jingxiao and Zhang, Shanshan and Jia, Jiaoyuan and Liu, Xianqiong and Zhang, Jie and Wang, Pan and Song, Xinhua and Che, Li and Liu, Ke and Ribback, Silvia and Cigliano, Antonio and Evert, Matthias and Wu, Hong and Calvisi, Diego F. and Zeng, Yong and Chen, Xin (2021) Distinct and Overlapping Roles of Hippo Effectors YAP and TAZ During Human and Mouse Hepatocarcinogenesis. CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 11 (4). pp. 1095-1117. ISSN 2352-345X,

Song, Xinhua and Liu, Xianqiong and Wang, Haichuan and Wang, Jingxiao and Qiao, Yu and Cigliano, Antonio and Utpatel, Kirsten and Ribback, Silvia and Pilo, Maria G. and Serra, Marina and Gordan, John D. and Che, Li and Zhang, Shanshan and Cossu, Antonio and Porcu, Alberto and Pascale, Rosa M. and Dombrowski, Frank and Hu, Hongbo and Calvisi, Diego F. and Evert, Matthias and Chen, Xin (2019) Combined CDK4/6 and Pan-mTOR Inhibition Is Synergistic Against Intrahepatic Cholangiocarcinoma. CLINICAL CANCER RESEARCH, 25 (1). pp. 403-413. ISSN 1078-0432, 1557-3265

Dong, Mingjie and Liu, Xianqiong and Evert, Katja and Utpatel, Kirsten and Peters, Michele and Zhang, Shanshan and Xu, Zhong and Che, Li and Cigliano, Antonio and Ribback, Silvia and Dombrowski, Frank and Cossu, Antonio and Gordan, John and Calvisi, Diego F. and Evert, Matthias and Liu, Yan and Chen, Xin (2018) Efficacy of MEK inhibition in a K-Ras-driven cholangiocarcinoma preclinical model. CELL DEATH & DISEASE, 9: 31. ISSN 2041-4889

Zhang, Shanshan and Song, Xinhua and Cao, Dan and Xu, Zhong and Fan, Biao and Che, Li and Hu, Junjie and Chen, Bin and Dong, Mingjie and Pilo, Maria G. and Cigliano, Antonio and Evert, Katja and Ribback, Silvia and Dombrowski, Frank and Pascale, Rosa M. and Cossu, Antonio and Vidili, Gianpaolo and Porcu, Alberto and Simile, Maria M. and Pes, Giovanni M. and Giannelli, Gianluigi and Gordan, John and Wei, Lixin and Evert, Matthias and Cong, Wenming and Calvisi, Diego F. and Chen, Xin (2017) Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice. JOURNAL OF HEPATOLOGY, 67 (6). pp. 1194-1203. ISSN 0168-8278, 1600-0641

Wang, Chunmei and Che, Li and Hu, Junjie and Zhang, Shanshan and Jiang, Lijie and Latte, Gavinella and Demartis, Maria I. and Tao, Junyan and Gui, Bing and Pilo, Maria G. and Ribback, Silvia and Dombrowski, Frank and Evert, Matthias and Calvisi, Diego F. and Chen, Xin (2016) Activated mutant forms of PIK3CA cooperate with RasV12 or c-Met to induce liver tumour formation in mice via AKT2/mTORC1 cascade. LIVER INTERNATIONAL, 36 (8). pp. 1176-1186. ISSN 1478-3223, 1478-3231